Live · 22 Sep 2026 SPX 7,764.70 +1.49% NDX 30,482.35 +2.83% VIX 14.66 -1.41% GOLD 4,361.50 -0.51% CL 90.66 -5.35% BTC 85,955.29 -0.75%
NAS100 30,482 +2.83% S&P 7,765 +1.49% GOLD $4,362 −0.51% BTC $85,955 −0.75% VIX 14.66 −1.41% live tape · as of 17:00 UTC
The Screen · Basic Materials · Specialty Chemicals

Solstice Advanced Materials Inc

SOLS · NASDAQ · USD · Market cap $9.1B · 4,100 employees

Solstice Advanced Materials, Inc.

FAIL · Does not pass the screen
57.31 USD

Screen close, 2026-09-18 · not a live quote
Last reviewed 4 days ago

Screened 2026-09-18 · the tape above runs as of 17:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
55.0155.0163.26

What this means: price 57.31 against the desk's fair-value range, base estimate 55.01, over the last year.

Current read
Markup ?
Screened · screened 2026-09-18
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price57.31 USD
Fair value55.01
Ethical score70.0/100
Our investment reviews on this name
2026-09-13Read Markup60.99-6.0% to today
2026-08-13Read Distribution57.31+0.0% to today
2026-07-02Read Markup83.06-31.0% to today

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Solstice Advanced Materials Inc holds its Markup at $57.31. Elevated stress, defensive posture warranted, held for 77 days.

As held on the ledger · 2026-09-18
PhaseMarkup
Quantitative stateElevated stress, defensive posture warranted, held for 77 days
Price at the screen$57.31
Valuation43.42 trailing · 16.98 forward price to earnings
Values screenFAIL · score 70.0
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 43.98% Below 33% Interest-bearing debt is 44.0% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 20.78% Below 49% Money owed to the company is 20.8% of assets, under the 49% limit. Pass
Revenue purity 0.00% Below 5% Only 0.0% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

What the Numbers Say It Is Worth

The Fair Value Range

55.01Conservative55.01Base case63.26Growth case 57.31Price

Fair value range in USD, drawn from the 2026-09-18 screen. The gold marker is the market price at the same screen. The price runs 4.0% above the base estimate.

The Street's Range
70.00Street low 81.50Street average 86.00Street high 57.31Price

Third-party analyst targets: 8 covering, consensus Strong Buy. The average target sits +42% from the screen price.

Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.

Price History & Projections
$88.9$68.1$47.3TODAY6m agoPROJECTIONStreet high$86.00 +11%Street avg$81.50 +5%Conservative$55.01 -29%Our fair value$55.01 -29%

Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-18 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Chemicals firm priced above its fair value

Picture a refrigerant plant running flat out today only to watch orders vanish when construction slows. Solstice Advanced Materials sits in exactly that spot, its shares at $58.38 against our $52.56 fair value and a negative margin of safety. The narrow moat and 18.2 times forward earnings leave little room for error in a business posting just 5 percent profit margins and 11 percent ROE.

We pass because the cyclical nature of refrigerants and electronic materials turns modest growth into a trap. Earnings can look steady at the top of the cycle, yet the same low multiple that appears reasonable often marks the moment volumes turn. Revenue expansion of 11 percent does not offset the exposure to industrial swings that have repeatedly crushed returns in this sector.

Analyst targets sit higher, yet those forecasts rarely bake in full downturn scenarios. The ethical screen clears, but valuation and cycle risk together remove any investment case. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E17.0xpriced for continued growth
Trailing P/E43.4xexpensive: the price assumes strong growth ahead
EPS, trailing1.32
EPS, forward3.37
Revenue growth+11.1%steady growth
Profit margin5.1%thin but positive margins
Return on equity11.3%a modest return on shareholder capital
FCF yield-0.30%
Dividend yield36.00%
Debt to equity1.53a meaningful debt load worth watching
Current ratio1.46adequate liquidity, worth monitoring
Short interest, float0.08%
52-week range40.43 - 90.80
MoatNARROW
Market cap$9.1B
Employees4,100

The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

SOLS trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-09-13 Markup · changed $60.99 +6.4% Entry 5

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 49%. The street (7 analysts) rates it hold, with a mean price target of $91.

2026-08-13 Distribution · changed $57.31 -31.0% Entry 4

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 31.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 49%. The street (7 analysts) rates it hold, with a mean price target of $91.

2026-07-18 Markup $83.06 +0.0% Entry 3

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 49%. The street (7 analysts) rates it hold, with a mean price target of $91.

2026-07-03 Markup $83.06 +0.0% Entry 2

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.

2026-07-02 Markup $83.06 Entry 1

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on SOLS

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in SOLS's Space

Screened names in the same industry · explore each on its own page.

The Political Ledger · Congressional Disclosures
Disclosures naming SOLS
DatePoliticianPartyTypeAmount
2026-08-11 Kelly Morrison Democrat sell 1K–15K
2026-08-11 Kelly Morrison Democrat sell 1K–15K
2026-08-05 Kevin Hern Republican sell 1K–15K
2026-08-05 Kevin Hern Republican sell 1K–15K
2026-08-05 Kevin Hern Republican sell 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $85.34 -9.0% $0.08 $911 -8.9%
2 months $81.89 -5.1% $0.08 $950 -5.0%
3 months $72.02 +7.9% $0.08 $1,080 +8.0%
6 months $50.19 +54.8% $0.15 $1,551 +55.1%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever SOLS does next, these words stay.

Solstice Advanced Materials Inc · SOLS · Markup · $57.31
Recorded 2026-09-18 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.